158 related articles for article (PubMed ID: 35683488)
1. Serum Nardilysin as a Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma.
Xu Y; Xiong Q; Yang Y; Weng N; Li J; Liu J; Yang X; Zeng Z; Zhang Z; Zhu Q
J Clin Med; 2022 May; 11(11):. PubMed ID: 35683488
[TBL] [Abstract][Full Text] [Related]
2. Nardilysin enhances ectodomain shedding of heparin-binding epidermal growth factor-like growth factor through activation of tumor necrosis factor-alpha-converting enzyme.
Nishi E; Hiraoka Y; Yoshida K; Okawa K; Kita T
J Biol Chem; 2006 Oct; 281(41):31164-72. PubMed ID: 16923819
[TBL] [Abstract][Full Text] [Related]
3. Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice.
Ikuta K; Fukuda A; Ogawa S; Masuo K; Goto N; Hiramatsu Y; Tsuda M; Kimura Y; Matsumoto Y; Kimura Y; Maruno T; Kanda K; Nishi K; Takaori K; Uemoto S; Takaishi S; Chiba T; Nishi E; Seno H
Gut; 2019 May; 68(5):882-892. PubMed ID: 29798841
[TBL] [Abstract][Full Text] [Related]
4. The metalloendopeptidase nardilysin (NRDc) is potently inhibited by heparin-binding epidermal growth factor-like growth factor (HB-EGF).
Hospital V; Nishi E; Klagsbrun M; Cohen P; Seidah NG; Prat A
Biochem J; 2002 Oct; 367(Pt 1):229-38. PubMed ID: 12095415
[TBL] [Abstract][Full Text] [Related]
5. N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration.
Nishi E; Prat A; Hospital V; Elenius K; Klagsbrun M
EMBO J; 2001 Jul; 20(13):3342-50. PubMed ID: 11432822
[TBL] [Abstract][Full Text] [Related]
6. Serum Nardilysin, a Surrogate Marker for Epithelial-Mesenchymal Transition, Predicts Prognosis of Intrahepatic Cholangiocarcinoma after Surgical Resection.
Yoh T; Hatano E; Kasai Y; Fuji H; Nishi K; Toriguchi K; Sueoka H; Ohno M; Seo S; Iwaisako K; Taura K; Yamaguchi R; Kurokawa M; Fujimoto J; Kimura T; Uemoto S; Nishi E
Clin Cancer Res; 2019 Jan; 25(2):619-628. PubMed ID: 30352908
[TBL] [Abstract][Full Text] [Related]
7. Ectodomain shedding of TNF-alpha is enhanced by nardilysin via activation of ADAM proteases.
Hiraoka Y; Yoshida K; Ohno M; Matsuoka T; Kita T; Nishi E
Biochem Biophys Res Commun; 2008 May; 370(1):154-8. PubMed ID: 18355445
[TBL] [Abstract][Full Text] [Related]
8. High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma.
Zhou CY; Dong YP; Sun X; Sui X; Zhu H; Zhao YQ; Zhang YY; Mason C; Zhu Q; Han SX
Cancer Med; 2018 Nov; 7(11):5525-5533. PubMed ID: 30358133
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of alpha-secretase cleavage of amyloid precursor protein by a metalloendopeptidase nardilysin.
Hiraoka Y; Ohno M; Yoshida K; Okawa K; Tomimoto H; Kita T; Nishi E
J Neurochem; 2007 Sep; 102(5):1595-1605. PubMed ID: 17555553
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of elevated serum soluble CD40 ligand levels as a diagnostic and prognostic tumor marker for pancreatic ductal adenocarcinoma.
Chung HW; Lim JB
J Transl Med; 2014 Apr; 12():102. PubMed ID: 24745825
[TBL] [Abstract][Full Text] [Related]
11. Nardilysin promotes hepatocellular carcinoma through activation of signal transducer and activator of transcription 3.
Kasai Y; Toriguchi K; Hatano E; Nishi K; Ohno M; Yoh T; Fukuyama K; Nishio T; Okuno M; Iwaisako K; Seo S; Taura K; Kurokawa M; Kunichika M; Uemoto S; Nishi E
Cancer Sci; 2017 May; 108(5):910-917. PubMed ID: 28207963
[TBL] [Abstract][Full Text] [Related]
12. Nardilysin and ADAM proteases promote gastric cancer cell growth by activating intrinsic cytokine signalling via enhanced ectodomain shedding of TNF-α.
Kanda K; Komekado H; Sawabu T; Ishizu S; Nakanishi Y; Nakatsuji M; Akitake-Kawano R; Ohno M; Hiraoka Y; Kawada M; Kawada K; Sakai Y; Matsumoto K; Kunichika M; Kimura T; Seno H; Nishi E; Chiba T
EMBO Mol Med; 2012 May; 4(5):396-411. PubMed ID: 22351606
[TBL] [Abstract][Full Text] [Related]
13. Low Serum miR-607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of Pancreatic Ductal Adenocarcinoma: A Preliminary Study.
Jiang D; Yuan X; Ni J; Shen L; Cai M; Xu L
Can J Gastroenterol Hepatol; 2021; 2021():8882129. PubMed ID: 34222137
[TBL] [Abstract][Full Text] [Related]
14. Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndrome.
Chen PM; Ohno M; Hiwasa T; Nishi K; Saijo S; Sakamoto J; Morita Y; Matsuda S; Watanabe S; Kuwabara Y; Ono K; Imai M; Inoue K; Murai T; Inada T; Tanaka M; Kita T; Kimura T; Nishi E
Int J Cardiol; 2017 Sep; 243():1-8. PubMed ID: 28747015
[TBL] [Abstract][Full Text] [Related]
15. Serum fibrinogen as a diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma.
Chung KH; Lee JC; Lee J; Cho IK; Kim J; Jang W; Yoo BC; Hwang JH
Pancreatology; 2020 Oct; 20(7):1465-1471. PubMed ID: 32873483
[TBL] [Abstract][Full Text] [Related]
16. Nardilysin is involved in autoimmune arthritis via the regulation of tumour necrosis factor alpha secretion.
Fujii T; Nishi E; Ito H; Yoshitomi H; Furu M; Okabe N; Ohno M; Nishi K; Morita Y; Morita Y; Azukizawa M; Okahata A; Tomizawa T; Kimura T; Matsuda S
RMD Open; 2017; 3(1):e000436. PubMed ID: 28955486
[TBL] [Abstract][Full Text] [Related]
17. Nardilysin regulates inflammation, metaplasia, and tumors in murine stomach.
Kimura Y; Ikuta K; Kimura T; Chiba T; Oshima H; Oshima M; Nishi E; Seno H
Sci Rep; 2017 Feb; 7():43052. PubMed ID: 28230087
[TBL] [Abstract][Full Text] [Related]
18. Identification of ANXA1 as a lymphatic metastasis and poor prognostic factor in pancreatic ductal adenocarcinoma.
Liu QH; Shi ML; Bai J; Zheng JN
Asian Pac J Cancer Prev; 2015; 16(7):2719-24. PubMed ID: 25854353
[TBL] [Abstract][Full Text] [Related]
19. Serum high mobility group box-1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma.
Chung HW; Lim JB; Jang S; Lee KJ; Park KH; Song SY
Cancer Sci; 2012 Sep; 103(9):1714-21. PubMed ID: 22703527
[TBL] [Abstract][Full Text] [Related]
20. Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma.
Dhayat SA; Traeger MM; Rehkaemper J; Stroese AJ; Steinestel K; Wardelmann E; Kabar I; Senninger N
Cancers (Basel); 2018 Sep; 10(9):. PubMed ID: 30217058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
